Net Talk.Com, Inc. (NTLK): Just another OTC POS junk stock.

Play Episode

6min

Proactive - Interviews for investors

Pluri CEO Yaky Yanay on pioneering cell-tech solutions for global needs

Pluri Inc. (NASDAQ:PLUR) CEO Yaky Yanay joined Proactive's Stephen Gunnion with more about the company’s progress in developing and commercializing its cell-based technology platform, highlighting recent partnerships, strategic financing, and future milestones. Pluri is a biotechnology company focused on manufacturing products derived from cells—including human, animal, and plant cells—for applications across industries such as healthcare, food, and agriculture. "We are taking this tiny organism, cells... and we create products out of them," Yanay explained. A key highlight was Pluri’s collaboration with Hemafund in Ukraine to enhance the country’s preparedness for radiation emergencies. Yanay detailed the use of PLX-R18, a placenta-based therapeutic developed with US federal agencies, which has shown potential to significantly improve survival rates following radiation exposure. The discussion also covered Pluri’s recent financing activities, including a $10 million raise and the acquisition of cacao company Kokomodo. These moves are part of Pluri’s broader expansion into the food sector, addressing shortages in coffee and cacao through cell cultivation in bioreactors. Looking ahead, Yanay emphasized a strong pipeline of deals for 2025, with a focus on sustainable, cell-based solutions for some of humanity’s biggest needs. For more interviews and updates, visit Proactive’s YouTube channel. Don’t forget to like this video, subscribe, and turn on notifications for future content. #PluriInc #BiotechInnovation #CellTherapy #SustainableTech #RadiationPreparedness #CoffeeCrisis #CacaoShortage #HealthcareTech #InvestmentNews #YakyYanay #ProactiveInvestors

Proactive - Interviews for investors

Genflow Biosciences adds AI power to gene therapy through Heureka Labs collaboration

Genflow Biosciences PLC (LSE:GENF, OTCQB:GENFF) CEO Dr Eric Leire talked with Proactive about the company’s new strategic partnership with US-based Heureka Labs, a spinoff of Duke University, to enhance its gene therapy research using AI technology. Leire said: “Every biotech in gene therapy should have an AI component. If you don't have that, you miss a critical tool to unlock value for your shareholders.” He stressed the need for a multi-omics approach—genomic, transcriptomic, and proteomic—to better understand gene expression and drug response, which traditional analysis methods struggle to fully capture. The partnership with Heureka Labs, which integrates deep AI and biological expertise, will initially support Genflow’s lead candidate, GF-1002, a SIRT-6 gene therapy targeting MASH (metabolic dysfunction-associated steatohepatitis). AI will help the company analyse complex preclinical data, including insights from nearly 700 mice tested, to understand mechanisms of action and identify likely responders—crucial in discussions with regulators such as the FDA and EMA. Leire also emphasised that the collaboration is scalable across Genflow’s pipeline, helping unlock synergies between programmes in liver, muscle, and eye diseases. For more interviews like this, visit Proactive’s YouTube channel. Don’t forget to give this video a like, subscribe to the channel, and enable notifications for future content. #GenflowBiosciences #GeneTherapy #AIinBiotech #BiotechNews #MASH #SIRT6 #HeurekaLabs #DrugDevelopment #MultiOmics #BiotechPartnership #FDA #EMA #PreclinicalResearch

Proactive - Interviews for investors

ATOME signs milestone EPC deal with Casale for Villeta project

ATOME PLC (AIM:ATOM) CEO Olivier Mussat talked with Proactive about a landmark milestone for the company’s Villeta green fertiliser project in Paraguay. The company has signed its first definitive engineering, procurement and construction (EPC) agreement with Swiss firm Casale S.A. Mussat explained that this agreement marks the world’s first large-scale green hydrogen fertiliser project to reach the EPC stage, underlining its global relevance. “It’s significant for us as a company because we’ve announced that we had been working on the front-end engineering and design for more than two years now,” Mussat said, noting the long-term collaboration with Casale. He highlighted Casale’s industry-leading expertise, describing the firm as the oldest ammonia licensor globally, with the ability to deliver complex, full-chain fertiliser projects. According to Mussat, the partnership serves as a strategic blueprint for Casale’s future growth. Looking ahead, ATOME aims to reach a final investment decision on the Villeta project by the end of the first half of the year. The company is working to finalise offtake agreements and complete financial documentation for both debt and equity funding. This includes a $115 million equity commitment from Hy24, with further syndication in progress. For more updates on green hydrogen and clean energy developments, visit Proactive’s YouTube channel. Like this video, subscribe, and turn on notifications to stay informed. #ATOMEPLC #GreenHydrogen #EPCContract #FertilizerProject #Casale #SustainableEnergy #CleanTech #HydrogenEconomy #ParaguayProjects #Yara #Hy24

Proactive - Interviews for investors

Reconnaissance Energy Africa provides drilling update on Prospect I in Namibia

Reconnaissance Energy Africa CEO Brian Reinsborough joined Steve Darling from Proactive to share a drilling update on Prospect I, located onshore Namibia within Petroleum Exploration Licence 073. Prospect I represents the company’s largest exploration target to date. It is estimated to hold approximately 365 million barrels of unrisked and 32 million barrels of risked prospective light to medium oil resources, or alternatively, 1.9 trillion cubic feet of unrisked and 140 billion cubic feet of risked prospective natural gas resources, based on a 100% working interest. Reinsborough reported that pre-construction activities are progressing on schedule and that pre-drill evaluations have been successfully completed. Drilling is planned to reach a target depth of 3,800 metres, with the flexibility to drill deeper depending on subsurface conditions—similar to the company’s approach with the Naingopo exploration well. The Otavi geological section is anticipated to range between 1,500 and 1,800 metres in thickness, depending on total drilling depth. Insights gained from the Naingopo well have significantly enhanced ReconAfrica’s understanding of the Damara Fold Belt, particularly regarding time-depth migration and structural interpretation of the Mulden and Otavi formations. This same reservoir zone at Naingopo exhibited more than 50 metres of reservoir-quality carbonates and oil shows, underscoring its potential. These developments mark an important step in advancing ReconAfrica’s exploration strategy in one of Africa’s most promising onshore hydrocarbon basins. #proactiveinvestors #reconnaissanceenergyafricaltd #tsxv #reco #otcqx #recaf #NamibiaOil #ProspectI #OilExploration #EnergyUpdate #OnshoreDrilling #OilAndGasNews #AfricanEnergy #OilDiscovery #EnergyInvesting

Followers	260
Posts	16595
Boards Moderated	2
Alias Born	12/09/2010

Volume:	-
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

NTLK Detailed Quote

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Go Ad-Free